The use of intramuscular injections is widely recommended to be avoided in patients who are prescribed anticoagulant agents, both oral and parenteral due to concerns of haematoma. Benzathine penicillin G (BPG), administered via intramuscular injection, is a vital treatment component for patients with rheumatic heart disease. BPG must be administered long term (for at least a decade) as part of treatment and alternative options to intramuscular injection are currently limited. Many of these patients with rheumatic heart disease will also require long term or lifelong anticoagulation. Our retrospective, single centre study of 48 adult and paediatric hospitalised patients, 29 of which were receiving concomitant anticoagulants, demonstrates no significant bleeding complications from intramuscular administration of BPG on the day of intramuscular injection and for 7 days post injection or until hospital discharge. In the absence of practical alternatives for patients with rheumatic heart disease, our local data supports continuing intramuscular injection of BPG in patients with rheumatic heart disease receiving anticoagulant medication.
Letter to the editor
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Australian Technical Advisory Group on Immunisation (ATAGI) (2018) Australian immunisation handbook. Australian Government Department of Health, Canberra
Public Health England (2017) Immunisation against infectious disease. Public Health England, London
Centers for Disease Control and Prevention (2015) Epidemiology and prevention of vaccine-preventable diseases. Public Health Foundation, Washington, DC
RHDAustralia (ARF/RHD writing group), National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand (2012) Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Cardiac Society of Australia and New Zealand, Sydney
Casajuana J, Iglesias B, Fabregas M, Fina F, Valles JA, Aragones R, Benitez M, Zabaleta E (2008) Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial. BMC Blood Disord 8:1. https://doi.org/10.1186/1471-2326-8-1
Raj G, Kumar R, McKinney WP (1995) Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med 155(14):1529–1531
Weibert RT, Lorentz SM, Norcross WA, Klauber MR, Jagger PI (1986) Effect of influenza vaccine in patients receiving long-term warfarin therapy. Clin Pharm 5(6):499–503
van Aalsburg R, van Genderen PJ (2011) Vaccination in patients on anticoagulants. Travel Med Infect Dis 9(6):310–311. https://doi.org/10.1016/j.tmaid.2011.09.001
LaVallee J, Royer R, Smith G (2017) Prevalence of bleeding complications following ultrasound-guided botulinum toxin injections in patients on anticoagulation or antiplatelet therapy. PM&R 9(12):1217–1224. https://doi.org/10.1016/j.pmrj.2017.06.002
Conflict of interest
The authors have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fox, E., Misko, J., Rawlins, M. et al. The risk of intramuscular haematoma is low following injection of benzathine penicillin G in patients receiving concomitant anticoagulant therapy. J Thromb Thrombolysis 50, 237–238 (2020). https://doi.org/10.1007/s11239-019-02013-6
- Benzathine penicillin G